Last Updated on eMC 06-06-2017 View medicine  | Ranbaxy (UK) Limited a Sun Pharmaceutical Company Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Reasons for adding or updating:

  • Company name change or merger

Reasons for adding or updating:

  • Change to section 2 - use in children/adolescents
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - driving and using machines
  • Change to section 3 - how to take/use
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
  • Change to information for healthcare professionals
  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - warnings and precautions

Reasons for adding or updating:

  • Improved presentation of PIL

Reasons for adding or updating:

  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - driving and using machines
  • Change to section 2 - excipient warnings
  • Change to section 3 - dose and frequency
  • Change to section 3 - how to take/use
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - marketing authorisation holder

Reasons for adding or updating:

  • Change to name of manufacturer
  • Change to MA holder contact details

Reasons for adding or updating:

  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC